About Novotech – The Asia Pacific Biotech CRO With Global Execution Capabilities

Source: Novotech

Biopharmaceutical Sponsors are facing increased challenges around participant recruitment and retention, lengthy timeframes, and trial costs. At the same time, sponsors are also looking to achieve greater diversification of their clinical trial participants and bring their innovative therapies to global patient populations.

On a global scale, Novotech’s focus on local relationships and expertise allows our clients to access a diverse, global patient population while also including regions of the world with faster patient recruitment. To reach these study goals, Asia-Pacific has become a key location, driven by its large patient population, the scale of medical facilities, government support for clinical trials, the strategic importance of Asian economies as end consumer markets, lower trial costs, and high-quality standards.

Take advantage of the world’s fastest-growing clinical trials region to accelerate your global clinical development by leveraging Novotech’s global footprint, deep relationships, and global operational infrastructure.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader